HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Retina and glaucoma: therapeutic considerations].

Abstract
This review describes the possible interactions between several retinal diseases, their treatment, and intraocular pressure (IOP). The use of the intravitreal route in the delivery of drugs to the retina has recently gained widespread acceptance with the development of the VEGF inhibitors and glucocorticoids such as triamcinolone. Although the intravitreal route offers high local concentrations in the vitreous, in the retina these advantages are offset by side effects, particularly short-term and chronic elevation of IOP. This review describes the clinical features of steroid glaucoma induced by triamcinolone or sustained-release systems of glucocorticoid drugs. Another aspect of the relationships between glaucoma and retina is also described: published reports of the occurrence of cystoid macular edema (CME) in eyes being treated with the prostaglandin analogs (PGAs) have led to concern regarding a possible causal relationship between the two. A review of the literature suggests that most PGA-treated eyes with CME had independent risk for development of CME, with a disruption of the blood-aqueous barrier: open or absent posterior capsule, history of dipivefrin-associated CME, epiretinal membrane, complicated cataract surgery, history of macular edema associated with branch retinal vein occlusion, ocular inflammation, and diabetes mellitus. In eyes at risk for CME, the use of PGAs is acceptable but must be prudent.
AuthorsF Aptel, P Denis
JournalJournal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 31 Issue 6 Pt 2 Pg. 2S61-4 (Jul 2008) ISSN: 1773-0597 [Electronic] France
Vernacular TitleRétine et glaucome: implications thérapeutiques.
PMID18957916 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Glucocorticoids
  • Prostaglandins, Synthetic
Topics
  • Glaucoma (chemically induced)
  • Glucocorticoids (administration & dosage, adverse effects)
  • Humans
  • Injections
  • Macular Edema (chemically induced)
  • Prostaglandins, Synthetic (adverse effects)
  • Retinal Diseases (drug therapy)
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: